Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Relmada Therapeutics Inc (RLMD)

125 + Investors. Track Smart Money conviction in RLMD. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +23
Streak
3Q ▲
Buyers last Q
65%

Smart Money Signals — RLMD

Based on 127 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q
For 3 consecutive quarters, more hedge funds added RLMD than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
127 hedge funds hold RLMD right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +165% more funds vs a year ago

fund count last 6Q
+79 new funds entered over the past year (+165% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 65% buying

84 buying46 selling
Last quarter: 84 funds were net buyers (47 opened a brand new position + 37 added to an existing one). Only 46 were sellers (22 trimmed + 24 sold completely). A clear majority buying is a strong confirmation signal.
📈

More new buyers each quarter (+11 vs last Q)

new funds entering per quarter
Funds opening a new RLMD position: 4 → 36 → 36 → 47. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔒

40% of holders stayed for 2+ years

■ 40% conviction (2yr+) ■ 23% medium ■ 37% new
51 out of 127 hedge funds have held RLMD for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
🚀

Acceleration phase — new buyers rushing in

11 → 4 → 36 → 36 → 47 new funds/Q
New funds entering each quarter: 4 → 36 → 36 → 47. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🏛️

Veteran-anchored — 59% veterans vs 37% newcomers

■ 59% veterans ■ 4% 1-2yr ■ 37% new
Entry-cohort mix of 129 holders: 76 (59%) are 2+ year veterans, 5 entered 1–2 years ago, and 48 (37%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
✅

Strong quality — 22% AUM from major funds

22% from top-100 AUM funds
33 of 126 holders rank in the top 100 by AUM, accounting for 22% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
5.9
out of 10
Moderate Exit Risk
Exit risk score 5.9/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — RLMD

In 2026 Q2, 84 hedge funds were net buyers of RLMD (47 opened a new position, 37 added to an existing one), while 46 reduced or exited (22 trimmed, 24 sold completely) — a 65% buyer ratio, indicating clear institutional accumulation. This marks 3 consecutive quarters of net institutional buying — a persistent conviction signal. 22% of total institutional value in RLMD is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +23 funds (more new holders than closures). Total institutional holders: 127.

Hedge Fund Ownership: RLMD

How many hedge funds hold RLMD — quarterly history vs. share price
Quarterly hedge fund ownership of RLMD vs. share price

Market Analysis: RLMD

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: RLMD

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Relmada Therapeutics Inc (RLMD) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much RLMD has moved relative to its sector benchmark (XLV) since the 2026 Q3 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End September 30, 2026 · 46d ago
RLMD
+11.7%
XLV
+12.1%

RLMD outperformed XLV by -0.4% since September 30, 2026.

Since 13F Filing Date November 14, 2026 · 1d ago
RLMD
+0.0%
XLV
+0.0%

Since the filing became public, RLMD outperformed XLV by +0.0% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

10 top-rated funds 5 high-conviction
Consensus
4.5
/ 10
breadth
×
Elite
3.4
/ 10
conviction
Hedge Fund Positioning: RLMD
2026 Q3 Stats Unlock in 4 days 125 + Investors

Track Smart Money conviction in RLMD. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q2) Prior (2026 Q1) Change
Funds Holding 125 104 20.19%
13F Shares 101M 84M 20.12%
Total Value $694M $580M 19.69%
New Positions 46 36 +10
Increased Positions 36 27 +9
Closed Positions 24 11 +13
Reduced Positions 22 25 -3
Total Calls 3 4 -25.0%
Total Puts 0 1 -100.0%
PUT/CALL Ratio 0.0 0.25 Bullish

Statistics: RLMD

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q3)

125 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in RLMD. Verified SEC 13F-HR filings.

QUARTER:
2026 Q3 filings are still coming in. Only funds that have filed so far are shown — top holders may not have reported yet. Full 13F data typically settles by ~50 days after quarter-end.
Top 25 RLMD holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Spruce Street Capital LP 4.14% 6,912,191 $26.1M
2 Jones Hill Capital LP 3.35% 5,237,628 $19.7M
3 Knott David M Jr 0.99% 480,000 $1.8M
4 Birchview Capital, LP 0.89% 408,100 $1.5M
5 HighVista Strategies LLC 0.42% 419,299 $1.6M
6 AdvisorShares Investments LLC 0.32% 670,861 $2.5M
7 Eventide Asset Management, LLC 0.10% 1,858,416 $7.0M
8 apricus wealth, LLC 0.08% 47,462 $179K
9 Parsons Capital Management Inc/Ri 0.07% 404,099 $1.5M
10 Persistent Asset Partners Ltd 0.04% 38,613 $146K
11 Virtus Investment Advisers, LLC 0.04% 47,719 $180K
12 Profund Advisors LLC 0.02% 195,555 $737K
13 Pale Fire Capital SE 0.01% 51,650 $195K
14 CV Advisors LLC 0.01% 20,000 $75K
15 Quantbot Technologies LP 0.01% 58,434 $220K
16 Mgo One Seven LLC 0.01% 100,000 $377K
17 Qube Research & Technologies Ltd 0.01% 1,911,342 $7.2M
18 Los Angeles Capital Management LLC 0.01% 420,451 $1.6M
19 Keebeck Wealth Management 0.00% 13,000 $49K
20 Bedel Financial Consulting, Inc. 0.00% 10,000 $38K
21 Walleye Capital LLC 0.00% 1,015,489 $3.8M
22 Renaissance Technologies LLC 0.00% 503,192 $1.9M
23 American Capital Advisory, LLC 0.00% 1,954 $7K
24 AlTi Global, Inc. 0.00% 31,975 $121K
25 Alps Advisors Inc 0.00% 140,319 $529K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Relmada Therapeutics Inc (RLMD)

What does the Smart Money Trend signal show for RLMD?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added RLMD than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for RLMD?

More buyers than sellers — 65% buying: Last quarter: 84 funds were net buyers (47 opened a brand new position + 37 added to an existing one). Only 46 were sellers (22 trimmed + 24 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for RLMD holders?

Strong quality — 22% AUM from major funds: 33 of 126 holders rank in the top 100 by AUM, accounting for 22% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held RLMD?

40% of holders stayed for 2+ years: 51 out of 127 hedge funds have held RLMD for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Relmada Therapeutics Inc (RLMD) following the 2026 Q3 hedge fund 13F filings?

As of today, RLMD has moved +0.0% since the 2026 Q3 13F filing date (November 14, 2026), compared to +0.0% for the XLV sector ETF — an outperformance of +0.0%. Since the quarter end (September 30, 2026), RLMD has gained +11.7% vs +12.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →